4//SEC Filing
Shumway Chris 4
Accession 0000950142-21-001061
CIK 0001733257other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 6:01 PM ET
Size
17.2 KB
Accession
0000950142-21-001061
Insider Transaction Report
Form 4
Crestovo Investor LLC
Director10% Owner
Transactions
- Purchase
Common Stock
2021-03-23$17.00/sh+735,294$12,499,998→ 12,641,441 total - Conversion
Series A Preferred Stock
2021-03-23−8,672,117→ 0 total→ Common Stock (8,672,117 underlying) - Conversion
Series B Preferred Stock
2021-03-23−1,064,466→ 0 total→ Common Stock (1,064,466 underlying) - Conversion
Series D Preferred Stock
2021-03-23−997,084→ 0 total→ Common Stock (997,084 underlying) - Conversion
Common Stock
2021-03-23+11,906,147→ 11,906,147 total - Conversion
Series C Preferred Stock
2021-03-23−1,172,480→ 0 total→ Common Stock (1,172,480 underlying)
Shumway Chris
Director10% Owner
Transactions
- Purchase
Common Stock
2021-03-23$17.00/sh+735,294$12,499,998→ 12,641,441 total - Conversion
Common Stock
2021-03-23+11,906,147→ 11,906,147 total - Conversion
Series B Preferred Stock
2021-03-23−1,064,466→ 0 total→ Common Stock (1,064,466 underlying) - Conversion
Series C Preferred Stock
2021-03-23−1,172,480→ 0 total→ Common Stock (1,172,480 underlying) - Conversion
Series D Preferred Stock
2021-03-23−997,084→ 0 total→ Common Stock (997,084 underlying) - Conversion
Series A Preferred Stock
2021-03-23−8,672,117→ 0 total→ Common Stock (8,672,117 underlying)
Footnotes (2)
- [F1]Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock is convertible at any time at the option of the holder, without payment of additional consideration, into Common Stock, on a one for one basis, has no expiration date and automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering.
- [F2]Held directly by Crestovo Investor LLC ("Crestovo"). Mr. Shumway exercises voting and investment power with respect to the shares held by Crestovo. Mr. Shumway disclaims beneficial ownership of the shares held directly by Crestovo, except to the extent of his pecuniary interest therein.
Documents
Issuer
Finch Therapeutics Group, Inc.
CIK 0001733257
Entity typeother
Related Parties
1- filerCIK 0001222119
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 6:01 PM ET
- Size
- 17.2 KB